INO Stock News

Popular stocks:

NVIDIA

TOP Stocks:

Shares of other companies:

China Evergrande New Energy Vehicle Group

Sonos

Cboe Global Markets

Inovio Pharmaceuticals (INO) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 5, 2023 (04:44)

Sector: Healthcare

The share price of Inovio Pharmaceuticals, Inc. (INO) now

Latest session on the 5th of December for

Inovio Pharmaceuticals, Inc. is negative

Trading Volume: 2012923

Open: 0.41 / High: 0.419 / Low: 0.386

What analysts predict: $1.2

52-week High/Low: $2 / $0.32

50/200 Day Moving Average: $0.407 / $0.645

This figure corresponds to the Average Price over the previous 50/200 days. For Inovio Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For Inovio Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in Inovio Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Inovio Pharmaceuticals stock price in 2023, 2024, 2025, 2026, 2027. How much will one Inovio Pharmaceuticals share be worth in 2023 - 2027?

When should I take profit in Inovio Pharmaceuticals stock? When should I record a loss on Inovio Pharmaceuticals stock? What are analysts' forecasts for Inovio Pharmaceuticals stock? What is the future of Inovio Pharmaceuticals stock? We forecast Inovio Pharmaceuticals stock performance using neural networks based on historical data on Inovio Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Inovio Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Inovio Pharmaceuticals shares. This happens once a day.

Historical and forecast chart of Inovio Pharmaceuticals stock

The chart below shows the historical price of Inovio Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Inovio Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Inovio Pharmaceuticals, Inc. a biotechnology company specializing in the discovery, development and commercialization of DNA drugs to treat, cure and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. Its SynCon immunotherapy design has the ability to disrupt the immune system’s tolerance to cancer cells and facilitate the cross-protection of strains against unrivaled and matched pathogens. The company participates in the conduct and planning of clinical trials of its DNA drugs for the treatment of HPV-associated cancers, including dysplasia of the cervix, vulva and anus; HPV-associated cancers, including cancers of the head and neck, cervix, anal canal, penis, vulva, and vagina; other HPV-associated diseases such as recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East respiratory syndrome (MERS); Lassa fever; Zika virus; and the COVID-19 virus (coronavirus). Its partners and employees are ApolloBio Corp., AstraZeneca PLC or AstraZeneca, Beijing Advaccine Biotechnology Co., Bill & Melinda Gates Foundation, Epidemic Preparedness Innovation Coalition (EPIR), Defense Advanced Research Projects Agency (DARPA), Life Sciences GeneOne. HIV Vaccine Threat Reduction Forensic Network, Defense Consortium Medical Weapons Agency (GCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergic and Infectious Diseases, Life Science Plumb Line, Regeneron Pharmaceuticals, Roche / Genentech, University Pennsylvania, University. Walter Reed Army Research Institute and Wistar Institute. The company also has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support the INO-4800 DNA research vaccine currently in Phase I of the COVID-19 clinical trials; and partnerships with the International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

Inovio Pharmaceuticals daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
Dec 07	0.42	0.41	0.43	5.90
Dec 08	0.43	0.41	0.44	5.37
Dec 09	0.41	0.40	0.42	3.73
Dec 10	0.42	0.41	0.43	4.55
Dec 11	0.41	0.39	0.42	7.00
Dec 12	0.42	0.40	0.43	6.00
Dec 13	0.42	0.41	0.43	3.98
Dec 14	0.43	0.41	0.43	4.55
Dec 15	0.41	0.40	0.42	4.56
Dec 16	0.40	0.39	0.41	4.98
Dec 17	0.41	0.39	0.41	5.50
Dec 18	0.40	0.40	0.42	5.10
Dec 19	0.40	0.39	0.41	5.49
Dec 20	0.41	0.40	0.42	4.86
Dec 21	0.42	0.41	0.43	6.56
Dec 22	0.44	0.43	0.45	3.03
Dec 23	0.43	0.43	0.44	2.28
Dec 24	0.44	0.42	0.45	6.79
Dec 25	0.43	0.41	0.44	6.24
Dec 26	0.43	0.41	0.45	7.41
Dec 27	0.43	0.42	0.44	4.89
Dec 28	0.42	0.41	0.43	3.82
Dec 29	0.41	0.40	0.42	5.06
Dec 30	0.41	0.39	0.42	5.72
Dec 31	0.41	0.40	0.42	5.77
Jan 01	0.40	0.39	0.41	4.91
Jan 02	0.39	0.38	0.40	4.57
Jan 03	0.38	0.37	0.40	7.19
Jan 04	0.36	0.35	0.38	5.79
Jan 05	0.35	0.34	0.36	5.08

Inovio Pharmaceuticals Daily Price Targets

Inovio Pharmaceuticals Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $0.42.
Positive dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 5.569%.
Pessimistic target level: 0.41
Optimistic target level: 0.43

Inovio Pharmaceuticals Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $0.43.
Positive dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 5.093%.
Pessimistic target level: 0.41
Optimistic target level: 0.44

Inovio Pharmaceuticals Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $0.41.
Negative dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 3.592%.
Pessimistic target level: 0.40
Optimistic target level: 0.42

Inovio Pharmaceuticals Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $0.42.
Positive dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 4.354%.
Pessimistic target level: 0.41
Optimistic target level: 0.43

Inovio Pharmaceuticals Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $0.41.
Negative dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 6.544%.
Pessimistic target level: 0.39
Optimistic target level: 0.42

Inovio Pharmaceuticals Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $0.42.
Positive dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 5.658%.
Pessimistic target level: 0.40
Optimistic target level: 0.43

INO (INO) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Dec.	0.39	0.37	0.42	11.00

Full forecast for 2023

Inovio Pharmaceuticals forecast for this year

Inovio Pharmaceuticals Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $0.390784. Pessimistic: $0.37. Optimistic: $0.42

Inovio Pharmaceuticals (INO) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	0.42	0.41	0.44	8.29
Mar	0.43	0.41	0.46	9.45
Mar	0.45	0.44	0.47	7.46
Apr	0.47	0.45	0.50	9.84
May	0.46	0.45	0.50	10.76
Jun	0.51	0.49	0.55	10.35
Jul	0.53	0.50	0.56	10.01
Aug	0.54	0.52	0.57	7.92
Sep	0.51	0.48	0.52	7.95
Oct	0.46	0.43	0.48	8.61
Nov	0.48	0.46	0.52	11.86
Dec	0.52	0.49	0.54	8.55

Full forecast for 2024

Inovio Pharmaceuticals (INO) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	0.51	0.49	0.54	9.76
Mar	0.50	0.47	0.52	9.69
Mar	0.51	0.47	0.53	11.66
Apr	0.54	0.51	0.58	10.90
May	0.58	0.57	0.60	5.44
Jun	0.56	0.51	0.58	11.85
Jul	0.56	0.53	0.59	9.62
Aug	0.57	0.55	0.61	9.82
Sep	0.58	0.55	0.61	9.62
Oct	0.53	0.52	0.55	4.78
Nov	0.55	0.51	0.58	11.27
Dec	0.55	0.52	0.57	8.79

Full forecast for 2025

Inovio Pharmaceuticals (INO) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	0.57	0.54	0.60	9.38
Mar	0.60	0.58	0.64	10.64
Mar	0.62	0.57	0.66	13.05
Apr	0.62	0.59	0.66	10.48
May	0.60	0.55	0.63	11.70
Jun	0.58	0.56	0.61	8.45
Jul	0.60	0.56	0.65	12.96
Aug	0.61	0.57	0.64	11.51
Sep	0.67	0.63	0.73	13.17
Oct	0.67	0.65	0.69	6.30
Nov	0.68	0.66	0.70	5.61
Dec	0.73	0.71	0.76	7.32

Full forecast for 2026

Inovio Pharmaceuticals (INO) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	0.74	0.72	0.79	9.20
Mar	0.79	0.77	0.84	8.40
Mar	0.74	0.70	0.77	9.40
Apr	0.75	0.74	0.77	4.30
May	0.76	0.75	0.78	4.11
Jun	0.73	0.71	0.78	9.12
Jul	0.78	0.75	0.83	10.37
Aug	0.82	0.77	0.84	7.60
Sep	0.78	0.72	0.81	10.81
Oct	0.79	0.76	0.83	9.18
Nov	0.86	0.82	0.92	11.09
Dec	0.86	0.80	0.92	13.03

Full forecast for 2027

Inovio Pharmaceuticals information and performance

Inovio Pharmaceuticals Address

6769 MESA RIDGE RD., SAN DIEGO, CA, US

Market Capitalization: 109 577 000 $

Market capitalization of the Inovio Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of INO shares in the company outstanding by the market price of one share.

EBITDA: -158 782 064 $

EBITDA of Inovio Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0152

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.63

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: -0.958

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 19.1

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.177

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 272986000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Medicenna Therapeutics Corp. (MDNA)

OrganiGram Holdings Inc. (OGI)

Bright Health Group, Inc. (BHG)

Schrodinger, Inc. (SDGR)

Zynex, Inc. (ZYXI)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/INO.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/INO.svg"> Inovio Pharmaceuticals (INO) Stock Forecast for 2023 – 2026. Sell or Buy?